{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:43:04Z","timestamp":1768405384465,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100022107","name":"Universite de Limoges","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jfo.2024.104152","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T23:58:00Z","timestamp":1714521480000},"page":"104152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["\u00c9tude randomis\u00e9e de l\u2019injection sous-conjonctivale de b\u00e9vacizumab (Avastin\u00ae) dans la n\u00e9o-vascularisation corn\u00e9enne"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6085-9840","authenticated-orcid":false,"given":"M.","family":"Rocher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Benayoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Quilbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Laribi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9224-2351","authenticated-orcid":false,"given":"P.","family":"Fournie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Leveziel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5882-7607","authenticated-orcid":false,"given":"M.-C.","family":"Trone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Bourcier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8387-0081","authenticated-orcid":false,"given":"P.-Y.","family":"Robert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2024.104152_bib0130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jfo.2013.03.002","article-title":"[Corneal neovascularization: epidemiological, physiopathological, and clinical features]","volume":"36","author":"Benayoun","year":"2013","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2024.104152_bib0135","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1080\/02713683.2022.2129071","article-title":"Effect of nintedanib nanothermoreversible hydrogel on neovascularization in an ocular alkali burn rat model","volume":"47","author":"Liu","year":"2022","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jfo.2024.104152_bib0140","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1080\/02713683.2022.2058018","article-title":"Vascular endothelial growth factor expression patterns in non-human papillomavirus-related pterygia: an experimental study on cell spot arrays digital analysis","volume":"47","author":"Mastronikolis","year":"2022","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jfo.2024.104152_bib0145","first-page":"805","article-title":"Gene expression profile of vascular endothelial growth factors (VEGFs) and platelet-derived growth factors (PDGFs) in the normal cornea","volume":"35","author":"Dan Cosnita","year":"2021","journal-title":"Vivo Athens Greece"},{"key":"10.1016\/j.jfo.2024.104152_bib0150","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-3768.2012.4445.x","article-title":"Effects of subconjunctival bevacizumab on corneal neovascularization: results of a prospective study","volume":"90","author":"Benayoun","year":"2012","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.jfo.2024.104152_bib0155","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ajo.2007.11.003","article-title":"Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model","volume":"145","author":"Papathanassiou","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104152_bib0160","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/ICO.0b013e318159019f","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization","volume":"27","author":"Bahar","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2024.104152_bib0165","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1755-3768.2008.01399.x","article-title":"Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization","volume":"87","author":"You","year":"2009","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.jfo.2024.104152_bib0170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bjophthalmol-2012-302137","article-title":"Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial","volume":"97","author":"Petsoglou","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104152_bib0175","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00417-007-0587-4","article-title":"Subconjunctival bevacizumab for corneal neovascularization","volume":"245","author":"Erdurmus","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104152_bib0180","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jfo.2010.07.007","article-title":"Injections sous-conjonctivales de b\u00e9vacizumab dans le traitement de la n\u00e9ovascularisation corn\u00e9enne","volume":"33","author":"Gueudry","year":"2010","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2024.104152_bib0185","first-page":"426","article-title":"In vivo measurement of corneal angiogenesis with video data acquisition and computerized image analysis","volume":"70","author":"Conrad","year":"1994","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"10.1016\/j.jfo.2024.104152_bib0190","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.exer.2008.08.007","article-title":"Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts","volume":"87","author":"Bock","year":"2008","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jfo.2024.104152_bib0195","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","article-title":"Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis","volume":"48","author":"Bock","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2024.104152_bib0200","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.preteyeres.2010.01.002","article-title":"Novel aspects of corneal angiogenic and lymphangiogenic privilege","volume":"29","author":"Ellenberg","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jfo.2024.104152_bib0205","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins","volume":"92","author":"Aiello","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jfo.2024.104152_bib0210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3341\/kjo.2013.27.4.235","article-title":"The effect of bevacizumab versus ranibizumab in the treatment of corneal neovascularization: a preliminary study","volume":"27","author":"Kim","year":"2013","journal-title":"Korean J Ophthalmol KJO"},{"key":"10.1016\/j.jfo.2024.104152_bib0215","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10792-013-9732-8","article-title":"The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularization","volume":"33","author":"Acar","year":"2013","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104152_bib0220","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/ICO.0b013e31817786ad","article-title":"Subconjunctival bevacizumab for corneal neovascularization","volume":"27","author":"Doctor","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2024.104152_bib0225","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/ICO.0b013e31819839f9","article-title":"Subconjunctival and intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy","volume":"28","author":"Oh","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2024.104152_bib0230","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00417-009-1170-y","article-title":"Avastin use in high risk corneal transplantation","volume":"247","author":"Vassileva","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104152_bib0235","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/ceo.12140","article-title":"Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1-year follow-up","volume":"42","author":"Nava-Casta\u00f1eda","year":"2014","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104152_bib0240","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1097\/ICO.0b013e31825ec407","article-title":"Recurrence of corneal neovascularization associated with lipid deposition after subconjunctival injection of bevacizumab","volume":"32","author":"Chu","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2024.104152_bib0245","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jfo.2015.06.006","article-title":"[Corneal neovascularisation treatments compared: subconjunctival bevacizumab injections and\/or photodynamic therapy]","volume":"38","author":"Hamdan","year":"2015","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2024.104152_bib0125","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1755-3768.2009.01585.x","article-title":"Subconjunctival bevacizumab for corneal neovascularization","volume":"88","author":"Zaki","year":"2010","journal-title":"Acta Ophthalmol (Copenh)"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551224000974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551224000974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T08:14:42Z","timestamp":1714551282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551224000974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0181551224000974"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2024.104152","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9tude randomis\u00e9e de l\u2019injection sous-conjonctivale de b\u00e9vacizumab (Avastin\u00ae) dans la n\u00e9o-vascularisation corn\u00e9enne","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2024.104152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104152"}}